• en
  • it
  • de
  • Statement regarding supply situation in light of the current Corona Virus outbreak

    To Whom it may concern

    The Corona Virus outbreak has triggered a number of emergency measures across China, though the Epicenter is only in the Wuhan / Hubei region. Due to this, most parts of China have extended holidays till Feb. 10th, 2020, some places even until Feb. 16th, 2020 as a precautionary measure.

    Due to this we expect some delays for our supplies from China, mainly due to port congestions, terminal closures and other delays because of lacking manpower.

    Such delays will not affect our production and ability to supply our end products, provided the outbreak control mechanisms do not lead into further closures or long lasting delays. We are closely monitoring the situation and are in contact with our suppliers in China. Right now we have no indications of further delays.

    Please be also assured that we have multi locational approved sources other than from China origin for our key raw and starting materials. Even here we are in touch with our suppliers in order to permanently check whether our sources outside of China face and issues in their supply chain.

    In case of any changes or supply issues due to further unexpected measures in China we will proactively inform you.

    Kind Regards,

    Global Supply Chain-Team

    10-Feb-2020

    More News and Fairs

    Breaking News: PharmaZell Group acquired by Bridgepoint

    The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint

    Statement regarding supply situation in light of the current Corona Virus outbreak

    To Whom it may concern The Corona Virus outbreak has triggered a number of emergency measures across China, though the Epicenter is only in the Wuhan / Hubei region. Due

    Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on

    Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)

    We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].

    Check out our new website!

    We are proud to share our new website with the pharmaceutical industry community.  As the PharmaZell Group has grown in the last ten years, so has our communication needs. We